Effects of alacepril and amlodipine on the renal injury induced by a high-cholesterol diet in rats

Journal of Hypertension

Volumn 17, Issue 12 SUPPL., 1999, Pages 1983-1986

  Atarashi, Keiichiro ^a   Takagi, Masao ^b   Minami, Mayumi ^a   Ishiyama, Akihiro ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b NONE

Author keywords

Alacepril; Amlodipine; Free radical scavenger; Lipid peroxides; Lipid induced glomerulosclerosis

Indexed keywords

ALACEPRIL; AMLODIPINE; ANTIHYPERTENSIVE AGENT; CHOLESTEROL; LIPID; MALONALDEHYDE; PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONFERENCE PAPER; CONTROLLED STUDY; GLOMERULOSCLEROSIS; HISTOPATHOLOGY; KIDNEY INJURY; LIPID BLOOD LEVEL; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RAT; SYSTOLIC BLOOD PRESSURE;

EID: 0033512523     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199917121-00031     Document Type: Conference Paper

References (14)

1. Moorhead JF, Chan MK, El-Nahas M, Varghese Z. Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet 1982; ii:1309-1311.
2. Guiijarro C, Keane WF. Lipid-induced glomerular injury. Nephron 1994; 67:1-6.
3. Ishiyama A, Atarashi K, Minami M, Takagi M, Kimura K, Goto A, et al. Role of free radicals in the pathogenesis of lipid-induced glomerulosclerosis in rats. Kidney Int 1999; 55:1348-1358.
4. Atarashi K, Ishiyama A, Takagi M, Minami M, Kimura K, Goto A, et al. Vitamin E ameliorates the renal injury of Dahl salt-sensitive rats. Am J Hypertens 1997; 10:1165-1195.
5. Richmond W. Preparation and properties of a cholesterol oxidase from Norcardia sp. and its application to the enzymatic assay of total cholesterol in serum. Clin Chem 1973; 19:1350-1356.
6. Lopes-Virella MF, Stone P, Ellis S, Colwell JA. Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem 1977; 23:882-884.
7. Yagi K. Micro-determination of lipoperoxide in blood plasma or serum. Vitamins (Japan) 1975; 49:403-405.
8. Fujita Y, Mori I, Kitano S. Determination of proteins by using the color reaction with pyrocatechol violet-molybdenum (IV) complex and protein. Chem Pharm Bull (Tokyo) 1984; 324:161-164.
9. Kimura K, Drozdova G, Hirata Y, Matsuoka H, Ishii M, Sugimoto T, et al. Effect of chronic administration of atrial natriuretic polypeptide on glomerular lesions in spontaneously hypertensive rats. Jpn Heart J 1990; 31:227-236.
10. Peric-Golia L, Peric-Golia M. Aortic and renal lesions in hypercholesterolemic adult, male, virgin Sprague-Dawley rats. Atherosclerosis 1983; 46:57-65.
11. Tolins JP, Raij L. Antihypertensive therapy and the progression of chronic renal disease. Are there renoprotective drugs? Semin Nephrol 1991; 11:538-548.
12. Matsumoto K, Miyazaki H, Fujii T, Yoshida K, Amejima H, Hashimoto M. Disposition and metabolism of the novel antihypertensive agent alacepril in rats. Arzneimittelforschung 1986; 36:40-46.
13. Noda Y, Mori A, Packer L. Free radical scavenging properties of alacepril metabolites and lisinopril. Res Commun Mol Pathol Pharmacol 1997; 96:125-136.
14. Chen L, Haught WH, Yang B, Saldeen TGP, Parathasarathy S, Mehta JL. Preservation of endogenous antioxidant activity and inhibition of lipid peroxidation as common mechanisms of antiatherosclerotic effects of vitamin E, lovastatin and amlodipine. J Am Coll Cardiol 1997; 30:569-575.